ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ViaLase-CE

More Like This

PR Newswire associated0

ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

Evolution Optiks Secures CE Marking for Groundbreaking Eye Care Device

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients

LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD)

Groundbreaking Study Reveals the Effectiveness of New RecoSMA Laser Treatment for Diabetic Foot